Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Effat A. Al-Judaibi has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Study of Gut Microbiota Diversity Among Migrant Workers in Jeddah, Makkah Region, Saudi Arabia, Using 16S rRNA Gene Sequencing

    by Effat A. Al-Judaibi

    Microbiome diversity varies significantly across countries and social groups due to geographic, ethnic, lifestyle, and dietary factors, with populations in traditional and rural settings tending to harbor more diverse microbial communities than those in industrialized urban environments. In Saudi Arabia, the influx of migrant workers from regions with distinct health and ecological backgrounds represents a public health concern. In particular, these workers may carry novel microbial species from their places of origin, thereby increasing the risk of infectious diseases spreading in the local population. This may also result in disruption of gut microbial homeostasis, thereby elevating risks related to infection, metabolic disorders, and disease susceptibility. Furthermore, the potential emergence of drug-resistant or locally uncommon microbial strains is particularly concerning. In this study, bacterial diversity was assessed in 28 fecal samples collected from migrant workers living in Saudi Arabia, using 16S rRNA gene sequencing targeting the V3–V4 regions. Operational taxonomic units (OTUs) were clustered at 97% sequence similarity, and alpha diversity indices (Shannon, Simpson, Chao1, ACE) were calculated to evaluate microbial richness and evenness. The results revealed considerable inter-individual variability, with Segatella copri, Peptostreptococcus, and Lachnospiraceae identified as dominant taxa across multiple samples. Principal component analysis (PCA) demonstrated distinct patterns of inter-individual variation, indicating compositional heterogeneity within the cohort. Functional predictions using PICRUSt2 suggested enrichment in metabolic pathways related to carbohydrate and amino acid processing. These findings offer a comprehensive characterization of the gut microbiome structure and predicted functionality in a population characterized by diverse geographic origins.

  • Open Access

    Syringic Acid Alleviates Doxorubicin-Induced Hepatotoxicity Through PI3K/Akt-Mediated Nrf-2/HO-1 Signaling Pathways in Male Rats

    by Maha Abdullah Alwaili, Thamir M. Eid, Amal S. Abu-Almakarem, Alaa Muqbil Alsirhani, Noorah Saleh Al-Sowayan, Rabab Mohamed Aljarari, Effat A. Al-Judaibi, Aljazi Abdullah AlRashidi, Maysa A. Mobasher, Karim Samy El-Said

    Syringic acid (SYA) is a significant phenolic compound with the potential for various biomedical uses, including uses of its hepatoprotective properties. Doxorubicin (DOX) is a drug used in the treatment of several tumors, but its side effects, particularly hepatotoxicity, limit its effectiveness. This study investigated the therapeutic effects of SYA on DOX-induced hepatic injury in rats. Molecular docking studies were performed using AutoDock Vina. Five groups of Sprague–Dawley rats (eight in each group) were studied. Gp1 was a negative control group; Gps2–5 was administered intraperitoneally (i.p.) with DOX at a dosage of 4 mg/kg once a week for a month; and Gp2 was left as a positive control group. Gps3–5 received oral SYA at doses of 25, 50, or 75 mg/kg/day, respectively, for a month. Histopathological, molecular, and biochemical analyses were conducted one month after the last SYA dosages were given. The findings demonstrated that by reversing biochemical changes and reducing oxidative stress and inflammation, SYA therapy considerably reduced DOX-induced hepatotoxicity in rats. These results implied that SYA may lessen the hepatotoxicity that DOX causes in rats.


  • Open Access

    Impact of Microbiota Diversity on Inflammatory Bowel Disease

    by Ashwag J. Alzahrani, Basma M. Al-Hebshi, Zolfekar A. Yahia, Effat A. Al-Judaibi, Khloud H. Alsaadi, Awatif A. Al-Judaibi

    Inflammatory bowel disease (IBD) is a chronic condition that includes two main types, Crohn’s disease (CD) and ulcerative colitis (UC), involving inflammation of the gastrointestinal (GI) tract. The exact cause of IBD is unknown but could be a combination of genetic, environmental, and immune system factors. This study investigated the impact of IBD on microbiota diversity by evaluating the differences in microbial composition and the microbiota of a control group (A) of healthy individuals and a group (B) of IBD patients. Sixty biopsies were collected from participants recruited from hospitals in Makkah, Saudi Arabia. Biopsy specimens were taken during colonoscopy examination, and bacterial identification was performed by extracting ribosomal DNA from sigmoid colon biopsies using a DNeasy Blood & Tissue Kit. Metagenomics and bioinformatics analyses were then conducted to analyze and compare the microbiota in the two groups. The results showed that the varieties of core microbiome species were 3.81% greater in the IBD patients than in the members of the control group. Furthermore, the differences between the groups were significantly greater than the variations within each group. Differences between the two groups were detected in the relative abundance of Clostridium nexile, Ruminococcus gnavus, Ruminococcus faecis, and Escherichia coli. These results indicate that microbiota could play a role in the pathogenesis of IBD and suggest that microbial diversity can serve as a biomarker for diagnosing the disease and monitoring its progression.


  • Open Access

    Comparative De Novo and Pan-Genome Analysis of MDR Nosocomial Bacteria Isolated from Hospitals in Jeddah, Saudi Arabia

    by Molook Alghamdi, Effat Al-Judaibi, Mohammed Al-Rashede, Awatif Al-Judaibi

    Multidrug-resistant (MDR) bacteria are one of the most serious threats to public health, and one of the most important types of MDR bacteria are those that are acquired in a hospital, known as nosocomial. This study aimed to isolate and identify MDR bacteria from selected hospitals in Jeddah and analyze their antibiotic-resistant genes. Bacteria were collected from different sources and wards of hospitals in Jeddah City. Phoenix BD was used to identify the strains and perform susceptibility testing. Identification of selected isolates showing MDR to more than three classes on antibiotics was based on 16S rRNA gene and whole genome sequencing. Genes conferring resistance were characterized using de novo and pan-genome analyses. In total, we isolated 108 bacterial strains, of which 75 (69.44%) were found to be MDR. Taxonomic identification revealed that 24 (32%) isolates were identified as Escherichia coli, 19 (25.3%) corresponded to Klebsiella pneumoniae, and 17 (22.67%) were methicillin-resistant Staphylococcus aureus (MRSA). Among the Gram-negative bacteria, K. pneumoniae isolates showed the highest resistance levels to most antibiotics. Of the Gram-positive bacteria, S. aureus (MRSA) strains were noticed to exhibit the uppermost degree of resistance to the tested antibiotics, which is higher than that observed for K. pneumoniae isolates. Taken together, our results illustrated that MDR Gram-negative bacteria are the most common cause of nosocomial infections, while MDR Gram-positive bacteria are characterized by a wider antibiotic resistance spectrum. Whole genome sequencing found the appearance of antibiotic resistance genes, including SHV, OXA, CTX-M, TEM-1, NDM-1, VIM-1, ere(A), ermA, ermB, ermC, msrA, qacA, qacB, and qacC.